Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Colorado Health Reporter.
Press releases published on September 19, 2025
KFSHRC akan Berpartisipasi dalam KTT C3 Davos of Healthcare™ Jepang
TOKYO, Sept. 20, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSHRC) telah mengumumkan partisipasinya dalam KTT C3 Davos of Healthcare™ Jepang, yang berlangsung pada 24 September 2025 dengan mengangkat tema “Kolaborasi …
킹파이살 전문병원 겸 연구센터 (KFSHRC), C3 다보스 어브 헬스케어™ 일본 정상회의 참가 예정
도쿄, Sept. 20, 2025 (GLOBE NEWSWIRE) -- 사우디아라비아의 킹파이살 전문병원 겸 연구센터 (KFSHRC)가 오는 2025년 9월 24일 열리는 C3 다보스 어브 헬스케어™ 일본 정상회의 (C3 Davos of Healthcare™ Japan Summit) 에 참여한다고 밝혔다. 이번 회의는 **“삼국 협력: 국경을 넘어 가교를 구축하는 헬스케어”(A Tri-Nation Collaboration: Building Bridges …
KFSHRC akan Menyertai Sidang Kemuncak C3 Davos of Healthcare™ di Jepun
TOKYO, Sept. 20, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSHRC) telah mengumumkan penyertaannya dalam Sidang Kemuncak C3 Davos of Healthcare™ di Jepun, yang akan berlangsung pada 24 September 2025 dengan tema “ …
Revive Therapeutics Announces Closing of Second Tranche of Private Placement
TORONTO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company dedicated to developing innovative therapeutics for critical medical needs, …
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
SAN CARLOS, Calif., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (“TIL …
Algernon Announces Preferred Share Class Approved at Annual and Special Meeting
VANCOUVER, British Columbia, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company announces the voting results at its annual and special …
AHS leader honored for decades of service in Alameda County
OAKLAND, Calif., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Sambo Ly, Alameda Health System’s (AHS’) manager of interpreter services, has won the Icon Award from Bay Area news station KPIX in recognition of her decades of service to refugees and community members …
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
NOVATO, Calif., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases, today reported the grant of …
Royalty Pharma to Present at Bernstein’s 2nd Annual Healthcare Forum
NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in a fireside chat at Bernstein’s 2nd Annual Healthcare Forum on Tuesday, September 23, 2025 at 2:50 p.m. ET. The webcast will be …
North Oaks Unveils $50 Million, 5-Story Specialty Clinic Expansion in Hammond
HAMMOND, La., Sept. 19, 2025 (GLOBE NEWSWIRE) -- The North Oaks Health System family joined with community leaders and dignitaries today to celebrate a major milestone with a ribbon cutting for North Oaks Clinic Building 3. The five-story, 96,000-square- …
PharmAla Files Amended and Restated Preliminary Base Shelf Prospectus
TORONTO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including its …
GENFIT Announces Discontinuation of its VS-01 Program in ACLF: VS-01 Development Refocused on UCD
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), September 19, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, …
Hydreight Announces Annual General Meeting Results
VANCOUVER, British Columbia, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS, OTC: HYDTF, FSE: SO6) (“Hydreight” or the “Company”), is pleased to announce that at the 2025 Annual General Meeting (“AGM”) virtually held on …
2025 Buying Guide - Best Mushroom Supplement Gummies 2025: Why MushCanyon Mushroom Gummies Are the Clear Winner
Washington DC, Sept. 19, 2025 (GLOBE NEWSWIRE) -- MushCanyon proudly launches the 2025 Buyer’s Guide: Best Mushroom Supplement Gummies, a definitive look at the year’s top functional mushroom chewables for focus, immunity, gut health, and daily energy. As …
Tevogen Commends HHS for Addressing Long COVID, Emphasizes TVGN 489’s Potential Impact for 20 Million Americans
WARREN, N.J., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today expressed its gratitude to the U.S. Department of Health and Human Services (HHS), Secretary Robert F. Kennedy, Jr., and the Trump …
2025 Buying Guide—Best Functional Mushroom Supplement 2025 – Brain, Weight Loss, Gut Health, Energy, -MushCanyon Adaptogens Lineup 2025
washington Dc, Sept. 19, 2025 (GLOBE NEWSWIRE) -- MushCanyon is proud to introduce its 2025 Adaptogens Lineup, a cutting-edge collection of functional mushroom supplements designed to meet the rising demand for natural solutions in brain health, weight …
Kensana Health Lands $120 million from GEM, Fuelling a Global Plant Based Medicine Revolution
NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Kensana Health Inc. (“Kensana”) today announced it has entered into a share subscription facility of up to $120 million with GEM Global Yield LLC SCS ("GEM"), a Luxembourg-based alternative investment group. …